The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)

•First published vaccine responses in those with monoclonal B cell lymphocytosis (MBL).•High-dose influenza vaccine responses in MBL and chronic lymphocytic leukemia (CLL).•Seroprotection: 63% (A/H1N1); 91% (A/H3N2); and 43% (B) for cohort (MBL and CLL).•Higher seroprotection rates for influenza B s...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 39; no. 7; pp. 1122 - 1130
Main Authors Whitaker, Jennifer A., Parikh, Sameer A., Shanafelt, Tait D., Kay, Neil E., Kennedy, Richard B., Grill, Diane E., Goergen, Krista M., Call, Timothy G., Kendarian, Saad S., Ding, Wei, Poland, Gregory A.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 12.02.2021
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0264-410X
1873-2518
1873-2518
DOI10.1016/j.vaccine.2021.01.001

Cover

Loading…